Prosecution Insights
Last updated: September 17, 2026
Application No. 18/776,567

PERSONAL CARE DISSOLVABLE SHEET, COMPOSITIONS, METHODS OF MAKING AND USING THE SAME

Non-Final OA §103
Filed
Jul 18, 2024
Priority
Jul 20, 2023 — provisional 63/527,898
Examiner
PALENIK, JEFFREY T
Art Unit
1615
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Ipx LLC
OA Round
2 (Non-Final)
54%
Grant Probability
Moderate
2-3
OA Rounds
1y 2m
Est. Remaining
81%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allowance Rate
474 granted / 882 resolved
-6.3% vs TC avg
Strong +27% interview lift
Without
With
+27.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
58 currently pending
Career history
935
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
48.1%
+8.1% vs TC avg
§102
19.6%
-20.4% vs TC avg
§112
19.0%
-21.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 882 resolved cases

Office Action

§103
DETAILED ACTION Status of the Application Receipt is acknowledged of Applicants’ Amendments and Remarks, filed 27 July 2026, in the matter of Application N° 18/776,567. Said documents have been entered on the record. The Examiner further acknowledges the following: The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-20 are pending, where claims 17-19 remain withdrawn from consideration. No claims have been added or canceled. Claims 2 and 15 have been amended. Claim 2 has been amended to change “the anionic surfactant” to “each of the first anionic surfactant and second anionic surfactant is independently selected from…”, thereby synchronizing the language with claim 1. Claim 15 is editorially amended. No new matter has been added. Thus, claims 1-16 and 20 continue to represent all claims currently under consideration. Information Disclosure Statement No new Information Disclosure Statements (IDS) have been filed for consideration. Withdrawn Rejections Rejection under 35 USC 112 Applicants’ amendment to claim 2 is sufficient in overcoming the previously raised antecedent basis issue. Said rejection is withdrawn. Rejection under 35 USC 103 Applicants’ remarks traversing the disclosure of Fowler are acknowledged, but not persuasive, except for those discussing the absence of the recited thickener component. In this respect, Applicants’ response is adequate in overcoming the previously raised obviousness rejection. Said rejection is withdrawn. New Rejections Due to the withdrawn rejection and reconsideration of the art, the following ground(s) of rejection are applied. Claim Rejections - 35 USC §103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the Examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicants are advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the Examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-16 and 20 are rejected under 35 U.S.C. 103 as being unpatentable over Tan et al. (US Pre-Grant Publication Nº 2021/0121373 A1). The instantly claimed invention is directed to a personal care composition comprising: a first anionic surfactant (e.g., sodium laureth sulfate); a second anionic surfactant (e.g., sodium lauryl sulfate); a third surfactant that is amphoteric (aka zwitterionic) (e.g., CAPB); a polyvinyl alcohol or derivative thereof; a thickener; an oil (e.g., mineral oil); and a suitable carrier (e.g., water). The composition is also recited as comprising an optional additive (e.g., conditioning agent). The remaining limitations discussing the preparation steps (i.e., heating, filtration, etc.) for the claimed composition are acknowledged, but are not considered to contribute to the overall patentability of the claimed composition. See MPEP §2113. Claim 20 recites a method of shampooing hair with a person care dissolvable sheet comprising: wetting the hair with water, applying the sheet onto the wet hair, foaming the sheet by massaging the hair, and rinsing the hair with water. Tan discloses a dissolvable solid article comprising dissolvable sheets, wherein said sheets comprise a water-soluble polymer and a first surfactant (see e.g., claim 16). Claim 17 discloses that the water-soluble polymer is polyvinyl alcohol. The practiced sheet composition is further taught as comprising a coating which is present on at least one surface of at least one of said two or more sheets, provided that said coating composition is not on any of the outer surfaces of the dissolvable solid article. The coating is compositionally defined as containing a second surfactant, a rheology modifier (aka thickener), a solvent (carrier), and a perfume (optional additive) (see e.g., claim 19). The first surfactant is further defined by the reference as being formed of anionic surfactants, zwitterionic surfactants, amphoteric surfactants, and combinations thereof. See ¶[0115]. The Examiner submits that the foregoing is considered to teach and suggest the first, second, and third surfactant limitations recited by claim 1. Regarding the recited oil component, the Examiner notes that the definition for the anionic surfactant(s) includes C10-18 n-paraffins (aka mineral oil). See ¶[0125]. Alternatively, the perfume may be provided as perfume oil capsules within the practiced sheets (see e.g., Table 18). Additional definitions for the anionic surfactants include both sodium laureth sulfate and sodium lauryl sulfate (see e.g., Tables 2 and 18; ¶[0120]). Such is considered to teach the limitations recited by instant claims 2-4. The limitations recited by claims 5-7 are directed to the amphoteric (zwitterionic) surfactant such as cocoamidopropyl betaine. Following the disclosure of ¶[0115], ¶[0134] further defines those zwitterionic surfactants that are encompassed by the practiced invention, and notably teaches using cocoamidopropyl betaine. The limitations recited by instant claims 8 and 9 are directed to the composition of claim 1 further comprising a nonionic surfactant. Claim 5 of the reference discloses that the “second” surfactant disclosed as being part of the coating component, will comprise a non-ionic surfactant. Additionally, the definition of the “first” surfactant in ¶[0115] includes nonionic surfactants as part of the blend of surfactants included therein. Paragraphs [0128]-[0130] further define the nonionic surfactants that are encompassed by the practiced invention. Therein, nonionic surfactants disclosed as being used or even preferred, include sorbitan monostearate (SPAN® 60), alkyl polyglucosides, and ethoxylated alcohols. The limitations recited by instant claims 10 and 11 are directed to the composition of claim 1 further comprising a cationic surfactant. Following the disclosure of ¶[0115], ¶[0135]-¶[0137] further define those cationic surfactants that are encompassed by the practiced invention, and notably teaches using diethyl quaternary amines (DEQA) and dimethylamines. See ¶[0136]. The limitations recited by instant claims 14 and 15 are directed to the carrier being further defined as a solvent such as water. Claim 6 further defines the coating composition as comprising the solvent which may be embodied by water. Paragraphs [0166]-[0169] disclose that the solvent may not only be water, but that the composition will most preferably contain less than 5% by weight of water and most preferably from 0.01-5 wt% of water. Lastly, regarding the intended use limitations recited by claim 16 and the method of claim 20, ¶[0159], for instance, discloses that one of the non-limiting uses for the practiced solid sheet include hand cleansing products, hair shampoo or other hair treatment products, body cleansing products, personal care substrates containing other applicable products, etc. Other disclosures in the reference provide similar teachings and suggestions for the recited use. See also ¶[0150] and ¶[0184]. Based on the combined teachings of the reference, the Examiner submits that a person of ordinary skill in the art would have had a reasonable expectation of success at producing the instantly claimed composition and arriving at the recited method of treatment. Therefore, the invention as a whole would have been prima facie obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, and absent a clear showing of evidence to the contrary. All claims under consideration remain rejected; no claims are allowed. Conclusion Due to the new grounds of rejection, this action is deemed non-final. Correspondence Any inquiry concerning this communication or earlier communications from the Examiner should be directed to Jeffrey T. Palenik whose telephone number is (571) 270-1966. The Examiner can normally be reached on 9:30 am - 7:00 pm; M-F (EST). If attempts to reach the Examiner by telephone are unsuccessful, the Examiner’s supervisor, Robert A. Wax can be reached on (571) 272-0623. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Jeffrey T. Palenik/ Primary Examiner, Art Unit 1615
Read full office action

Prosecution Timeline

Jul 18, 2024
Application Filed
Oct 08, 2024
Response after Non-Final Action
Apr 27, 2026
Non-Final Rejection mailed — §103
Jul 27, 2026
Response Filed
Aug 21, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12729131
Pigment Comprising Particles Each Containing Calcium-Titanium Composite Oxide As Main Component, Method For Producing Same, And Use Of Same
3y 3m to grant Granted Sep 08, 2026
Patent 12714674
JAK INHIBITORS HAVING A SPECIFIC PARTICLE SIZE DISTRIBUTION
3y 4m to grant Granted Aug 25, 2026
Patent 12708695
SOFT TISSUE ADHESIVE COMPOSITION OF ALPHA-TCP AND PHOSPHORYLATED AMINO ACID
2y 5m to grant Granted Aug 18, 2026
Patent 12698459
CONTROLLED RELEASE, BIODEGRADABLE CORE-SHELL MICROCAPSULE COMPOSITIONS
4y 10m to grant Granted Aug 04, 2026
Patent 12691043
FRAGRANCE COMPOSITION
3y 1m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
54%
Grant Probability
81%
With Interview (+27.1%)
3y 4m (~1y 2m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 882 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month